“With their policies, [states] have allowed the financial sector to weigh more, for technology companies to be more powerful or for pharmaceutical companies to operate in a more extractive way,” said Professor Mariana Mazzucato (UCL Institute for Innovation and Public Purpose).
Read: El Pais (£)(Spanish)